Cargando…
SEOM clinical guidelines in gestational trophoblastic disease (2017)
Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD.
Autores principales: | Santaballa, A., García, Y., Herrero, A., Laínez, N., Fuentes, J., De Juan, A., Rodriguez Freixinós, V., Aparicio, J., Casado, A., García-Martinez, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785593/ https://www.ncbi.nlm.nih.gov/pubmed/29149431 http://dx.doi.org/10.1007/s12094-017-1793-0 |
Ejemplares similares
-
SEOM Clinical Guideline in ovarian cancer (2016)
por: Santaballa, A., et al.
Publicado: (2016) -
SEOM clinical guidelines for endometrial cancer (2017)
por: Santaballa, A., et al.
Publicado: (2017) -
SEOM clinical guidelines to primary prevention of cancer (2018)
por: Bayo, J., et al.
Publicado: (2019) -
SEOM clinical guidelines on cardiovascular toxicity (2018)
por: Virizuela, J. A., et al.
Publicado: (2019) -
SEOM clinical guideline on unknown primary cancer (2017)
por: Losa, F., et al.
Publicado: (2017)